Research

Posts about James Smither written by kathrynwelds

This week’s #OTalk is on the topic of developing outcome measures and will be hosted by Alison Laver-Fawcett (@alisonlaverfaw) from York St John University in the UK. Here’s what Alison had to say:…

The goal of this randomized, blinded, crossover clinical trial was to determine whether Nuedexta (dextromethorphan and quinidine) enhanced speech, swallowing, and salivation in patients with ALS. Sixty patients with amyotrophic lateral sclerosis (ALS) received either Nuedexta or placebo for 28 to 30 days, followed by a 10 to 15-day washout period. Subsequently, patients were switched to the opposite treatment arm for the remaining days of the trial. The primary endpoint was a reduction in the self-report Center for Neurologic Study Bulbar Function Scale (CNS-BFS) score. The rater-administered ALS Functional Rating Scale Revised was the principal secondary endpoint. The CNS-BFS score improved with active treatment, decreasing from a mean of 59.3 in the placebo arm of the trial to 53.5 during the drug-treatment arm (p < 0.001). Each of the individual domains of bulbar function interrogated by the CNS-BFS responded to treatment with Nuedexta as follows: salivation: 15.8 versus 14.3 (p = 0.004); speech: 24.6 versus 22.2 (p = 0.003); swallowing: 18.9 versus 17.1 (p = 0.009). Similarly, the bulbar component of the ALS Functional Rating Scale Revised improved with active treatment (p = 0.003), although the drug did not affect the motor and respiratory components of this scale. This study is unique for several reasons. Firstly, it was driven by patient reports of improved speech and swallowing while taking Nuedexta for control of emotional lability. Secondly, the study was conducted over a short duration (70 days), and thirdly, a self-report scale was selected as the principle outcome measure. Considering the importance of bulbar functions, these results, if confirmed, point to an additional use of Nuedexta as an adjunct to the management of ALS.

Professional Homework Helpline with Custom Writing Services

Kudos Personal Showcase for Dr Hassen Al-Amin at Weill Cornell Medical College in Qatar, Qatar

Find out what’s involved in volunteering as a Tournament Official or Course Rater with the NCGA. Apply to volunteer now and experience great benefits.

Title 24 HERS information, California Title 24 energy compliance, Title 24 reports for all building projects. CEPE certified, experienced, low rates, same day turnaround. Call toll-free (888)828-9488 for more information. Title 24 Express.

Rating Field Inspector candidates will no longer be required to pass a written examination to become a certified RESNET Rating Field Inspector (RFI). July 1, 2015 is the implementation date …

Register to gain insights into the newly developed guidance on improving data quality and reducing site/patient burden in remote rare disease trials.

central resource for events in human genetics and molecular biology

This is the time of year when a lot of law firms administer multi-rater feedback surveys—these can include “360-degree feedback” or simply “360’s”, as well as peer reviews and upward evaluation surveys. What they all have in common is that…